See also this year's filing and all EDGAR filings for this company.
PDF Report 0001156039_2020_Elevance_Health_Inc.pdf
Logs
| warning | NetIncome node detected by IncomeLoss name heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 107.78183716075156, 'aggregate_val': 104213000000, 'exp_sum': 958000000, 'exp_to_value': {'PremiumsEarned': 0, 'InvestmentIncome': 1005000000, 'InsuranceCommissionsAndFees': 0, 'remainder_Revenues': -47000000}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 137.95895096921322, 'aggregate_val': 121867000000, 'exp_sum': 877000000, 'exp_to_value': {'PremiumsEarned': 0, 'InvestmentIncome': 877000000, 'InsuranceCommissionsAndFees': 0, 'remainder_Revenues': 0}} |
Graph
Absolute values for 0001156039, Elevance Health Inc
| xvar | xval | |
|---|---|---|
| 0 | Investments | 0 |
| 1 | SeparateAccountAssets | 0 |
| 2 | PremiumsReceivable | 5,173,000,000 |
| 3 | DeferredPolicyAcquisitionCosts | 0 |
| 4 | ReinsuranceRecoverables | 0 |
| 5 | IntangibleAssets | 29,174,000,000 |
| 6 | AssetsCurrent | 39,033,000,000 |
| 7 | AssetsNonCurrent | 3,133,000,000 |
| 8 | remainder_Assets | 940,000,000 |
| 9 | LiabilityForClaimsAndClaimsAdjustmentExpense | 12,651,000,000 |
| 10 | PolicyholderContractDeposits | 3,050,000,000 |
| 11 | LiabilitiesCurrent | 23,617,000,000 |
| 12 | UnearnedPremiums | 1,017,000,000 |
| 13 | ReinsurancePayable | 0 |
| 14 | LongTermDebt | 19,207,000,000 |
| 15 | remainder_Liabilities | -13,817,000,000 |
| 16 | PolicyholderBenefitsAndClaims | 81,712,806,495 |
| 17 | SellingGeneralAndAdministrativeExpense | 15,333,072,698 |
| 18 | DeferredPolicyAcquisitionCostAmortizationExpense | 0 |
| 19 | remainder_Expenses | 1,094,408,841 |
| 20 | PremiumsEarned | 4,577,607,831 |
| 21 | InvestmentIncome | 1,010,921,601 |
| 22 | InsuranceCommissionsAndFees | 0 |
| 23 | remainder_Revenues | 89,998,443,503 |
| 24 | Revenues_Y1 | 93,776,702,312 |
| 25 | Revenues_Y2 | 95,897,783,212 |
| 26 | Revenues_Y3 | 95,538,201,189 |
| 27 | Revenues_Y4 | 95,596,134,916 |
| 28 | Revenues_Y5 | 95,586,972,935 |
| 29 | remainder_NetIncome | 0 |
| 30 | remainder_ComprehensiveNetIncome | -1,015,209,539 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 77,453,000,000 |
| 1 | Liabilities | 45,725,000,000 |
| 2 | Expenses | 98,140,288,034 |
| 3 | Revenues | 95,586,972,935 |
| 4 | StockholdersEquity | 31,728,000,000 |
| 5 | NetIncome | -2,553,315,100 |
| 6 | ComprehensiveNetIncome | -3,060,919,869 |
| 7 | BaseVar | 5,296,601,648,071 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.603 |
| 9 | EconomicCapitalRatio | 1.29 |
Edgar->Model Mapping
Feature Distribution
Company Valuation
Change over Time
